NOFSA statement on generic bisphosphonates.
Hough
Stephen
S
D019386:Alendronate / Q000493:pharmacokinetics / Q000627:therapeutic use*; D050071:Bone Density Conservation Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016568:Drugs, Generic / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D010024:Osteoporosis / Q000188:drug therapy*; D013019:South Africa
D050071:Bone Density Conservation Agents; D016568:Drugs, Generic; D019386:Alendronate